Hints and tips:
...All assets may perform badly under stagflation, but we’d rather own Pepsi, Johnson & Johnson, Kimberly-Clark, Bristol-Myers et al than sit and watch our cash lose its earnings power....
...Bristol-Myers Squibb, a mammoth US drugmaker on the brink of completing a $90bn merger with Celgene — one of the largest in pharma history — is Starboard’s latest target....
...Tech-set comes to work crowd ahead of big IPOs It has been an active start to the year for dealmakers, with a number of transactions already announced, including Bristol-Myers Squibb’s $90bn deal for rival...
...What really happened at Northern Rock, Royal Bank of Scotland et al? This gives you a clearer idea....
...al?...
...Again, Hugenholtz et al, point out that the majority of cases brought under the Directive have been about databases that would have been created anyway - telephone numbers, television schedules, concert...
International Edition